Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis. | Bioengineered | 2021 | 34180358 | PubTator, text mining | PubMed |
| Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma. | Front Oncol | 2021 | 34178677 | PubTator, text mining | PubMed |
| Cross-Tissue Transcriptomic Analysis Leveraging Machine Learning Approaches Identifies New Biomarkers for Rheumatoid Arthritis. | Front Immunol | 2021 | 34177888 | PubTator, text mining | PubMed |
| Acute Effects on the Human Peripheral Blood Transcriptome of Decompression Sickness Secondary to Scuba Diving. | Front Physiol | 2021 | 34177613 | PubTator, text mining | PubMed |
| Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. | BMC Cancer | 2021 | 34174849 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence. | Int J Stem Cells | 2021 | 34158414 | PubTator, text mining | PubMed |
| Umbilical Cord Mesenchymal Stem Cells for Inhibiting the Fibrosis and Autoimmune Development in HOCl-Induced Systemic Scleroderma Mouse Model. | Int J Stem Cells | 2021 | 34158413 | PubTator, text mining | PubMed |
| Multiomic analysis of the function of SPOCK1 across cancers: an integrated bioinformatics approach. | J Int Med Res | 2021 | 34156309 | PubTator, text mining | PubMed |
| Advantages and challenges of stem cell therapy for osteoarthritis (Review). | Biomed Rep | 2021 | 34155451 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury. | Front Immunol | 2021 | 34149726 | PubTator, text mining | PubMed |
| The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming. | Front Immunol | 2021 | 34149687 | PubTator, text mining | PubMed |
Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Secreted by BMSCs Regulates Activated Astrocytes by Inhibiting NF-κB Signaling Pathway to Ameliorate Blood Brain Barrier Damage After Intracerebral Hemorrhage. | Neurochem Res | 2021 | 34145502 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. | Adv Drug Deliv Rev | 2021 | 34139255 | PubTator, text mining | PubMed |
| Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro. | Sci Rep | 2021 | 34127731 | PubTator, text mining | PubMed |
| Placental chorionic plate-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating macrophage polarization via secreting TSG-6. | Stem Cell Res Ther | 2021 | 34112260 | PubTator, text mining | PubMed |
| Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy. | Cell Death Dis | 2021 | 34108448 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed circRNAs, miRNAs, and Genes in Patients Associated with Cartilaginous Endplate Degeneration. | Biomed Res Int | 2021 | 34104646 | PubTator, text mining | PubMed |
| Reduced hyaluronan cross-linking induces breast cancer malignancy in a CAF-dependent manner. | Cell Death Dis | 2021 | 34099638 | PubTator, text mining | PubMed |
| The Calcium-Sensing Receptor Is Involved in Follicle-Stimulating Hormone-Induced Cumulus Expansion in in vitro Cultured Porcine Cumulus-Oocyte Complexes. | Front Cell Dev Biol | 2021 | 34095106 | PubTator, text mining | PubMed |
| HA and HS Changes in Endothelial Inflammatory Activation. | Biomolecules | 2021 | 34072476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=49